Because cell-surface gC1qR is known to increase during cancer progression and regulates lamellipodia formation and cell migration [3, 5, 12], antibody neutralization of cell-surface gC1qR might be an effective strategy for treating cancer. This evidence concerns the gene C1QBP and cancer.